Skin Layer Grown in Lab Could Replace Animal Testing|
Monday, April 28, 2014
Skin layer grown from human stem cells could replace animals in drug and cosmetics testing.
Novartis Announces Portfolio Transformation
Wednesday, April 23, 2014
Company launches a major overhaul of its business, unveiling a series of multibillion-dollar deals with GSK and Eli Lilly.
Scripps Research Institute Creates New Drug Discovery Initiative
Wednesday, April 16, 2014
Scripps Advance is a new drug discovery initiative to translate early-stage biomedical research projects into clinical development candidates.
4SC Discovery Receives €450K Epigenetic Research Grant
Tuesday, April 15, 2014
4SC Discovery GmbH will receive a EUR 450,000 grant from the EU for the research of new compounds targeting cardiovascular diseases such as stroke.
CyBio to be Merged into Analytik Jena
Friday, April 11, 2014
Analytik Jena AG is planning to merge the business of its subsidiary CyBio AG with its core business in the Life Science business unit.
Agilux Laboratories Appoints Head of GLP Bioanalysis
Wednesday, April 09, 2014
Dr LeLacheur appointed Head of GLP Bioanalysis for Agilux's pharmaceutical development services.
AstraZeneca, MRC Collaboration to Create New Centre for Early Drug Discovery
Monday, March 31, 2014
The Companies today announced the groundbreaking collaboration aimed at better understanding the mechanisms of human disease. The collaboration will see the creation of a joint research facility at AstraZeneca’s new R&D centre in Cambridge in the UK.
GSK, EMBL-EBI and Sanger Institute Launch Target Validation Initiative
Thursday, March 27, 2014
Centre for Therapeutic Target Validation will utilise genomics and big data to drive drug discovery.
Adocia Confirms Positive Clinical Results for its BioChaperone® Combo
Friday, March 21, 2014
BioChaperone Combo is the first combination based on insulin glargine to show a fast and long action in type I diabetic patients.